CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 937 enrolled
Drug / intervention
Exposure to high altitudeother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04751292
NCT04751292N/ACompleted

HIGH Altitude CArdiovascular REsearch Latin America Population Study

Istituto Auxologico Italiano·observational·Posted Feb 12, 2021·Updated Mar 1, 2024

In Brief

An observational study evaluating Exposure to high altitude for Hypertension and 5 related conditions. Completed, enrolled 937 participants across 1 site.

Detailed Summary

High blood pressure (BP) is one of the principal cardiovascular risk factors. While BP levels and hypertension prevalence are well characterized in many populations, information on BP and on cardiovascular risk profile in high altitude inhabitants is limited and frequently contradictory, especially in the large highland populations of South America. The information on the effects of permanent high altitude exposure on cardiovascular variables including BP may be relevant in the light of the known BP-increasing effect of acute exposure to high altitude hypoxia. This information may have practical implications for millions of people living at elevated altitudes in Asia, South America and Africa. The inconclusive epidemiological evidence on BP and cardiovascular risk in high altitude dwellers may be the result of several factors, among them: 1) confounding by genetic and socio-economic factors; 2) imperfect methods of BP evaluation, in particular lack of data on ambulatory and home BP (both methods considered superior to conventional clinic BP in the assessment of exposure to high BP). On this background, the general aim of the study is to compare blood pressure levels and cardiovascular risk profile among population-based samples of subjects residing in Peruvian communities living at different altitudes.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesPeru

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedFeb 12, 2021
Enrollment StartJan 26, 2021
Primary CompletionDec 30, 2023
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 5.4 years ago

Interventions

Exposure to high altitudeother

permanence at high (\>2500 m) altitude; permanence is defined as being born and living at high altitude with the total time spent at lower altitudes not exceeding 2 years in the past 10 years